CD8A and neoplasm: Instead, the study by Pfister et al. suggested the aberrantly activated, PD-1+CD8+ TRM produced large amounts of TNF, that led to ineffective immunosurveillance, contributed to tumour progression, and decreased immunotherapy efficacy [117].